Incident heart failure, arrhythmias and cardiovascular outcomes with sodium‐glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database

AIM: To investigate the impact of sodium‐glucose cotransporter 2 (SGLT2) inhibitors on the risk of incident heart failure and adverse cardiovascular outcomes. METHODS: All patients with diabetes who were registered between January 2018 and December 2019 were identified from a federated electronic me...

Descripción completa

Detalles Bibliográficos
Autores principales: Fawzy, Ameenathul Mazaya, Rivera‐Caravaca, José Miguel, Underhill, Paula, Fauchier, Laurent, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087187/
https://www.ncbi.nlm.nih.gov/pubmed/36054168
http://dx.doi.org/10.1111/dom.14854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087187/
https://www.ncbi.nlm.nih.gov/pubmed/36054168
http://dx.doi.org/10.1111/dom.14854

Ejemplares similares